Atara receives FDA rejection, future uncertain
The bad news just keeps coming for Thousand Oaks-based Atara Biotherapeutics. Nearly a year after the biotechnology company laid off 50% of its workforce after one rejection from the U.S. Food and Drug Administration, Atara received another one on Jan. 12. In this notice, Atara, a company specializing in developing transformative therapies for patients with Read More →
Dignity Health appoints new Central Coast market president
Dignity Health, which has seven award-winning hospitals on the Central Coast, has appointed BJ Predum as its Central Coast Market President, effective Feb. 2. Announced Jan. 26, Predum will be responsible for the strategic planning, growth, operations, financial performance, and support services across the Dignity Health Central Coast market. Predum previously served as the Dignity Read More →

Community Memorial Healthcare expands Ventura cancer program
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Amgen snaps up Dark Blue for $840M
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Covered CA faces big hurdles in 2026, says executive director
The holiday season usually brings a lot of light and joy, but for a majority of Americans, decisions in regards to healthcare in 2026 will also need to be made. Affordable Care Act subsidies, or tax credits, that went into effect in 2021 as part of the American Rescue Plan Act are set to expire Read More →







